SCREENING FOR EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONS ASSOCIATED TO TYROSINE-KINASE INHIBITORS IN LUNG ADENOCARCINOMA PATIENTS FROM ARGENTINA

被引:0
|
作者
Poleri, Claudia [1 ]
Castro, Marcelo [2 ]
Guasti, Marcelo [3 ]
Plotquin, Martin [3 ]
Bramuglia, Guillermo F.
机构
[1] Fdn Investigar, Buenos Aires, DF, Argentina
[2] Uba Fdn Investigar, Area Hematol, Fac Farm & Bioquim, Buenos Aires, DF, Argentina
[3] AstraZeneca, Dept Med, Buenos Aires, DF, Argentina
关键词
EGFR; tirosine kinase inhibitors; Adenocarcinoma;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S1017 / S1018
页数:2
相关论文
共 50 条
  • [21] Mutations in the epidermal growth factor receptor gene and effects of EGFR-tyrosine kinase inhibitors on lung cancers
    Fukui T.
    Mitsudomi T.
    General Thoracic and Cardiovascular Surgery, 2008, 56 (3) : 97 - 103
  • [22] Clinical outcomes of lung adenocarcinoma patients harboring uncommon epidermal growth factor receptor (EGFR) mutations treated with EGFR-tyrosine kinase inhibitors (TKIs)
    Si, Jinfei
    Gu, Xiaodong
    Wang, Wenxian
    Ying, Shenpeng
    Song, Zhengbo
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (05) : 1624 - 1634
  • [23] Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harboring Rare Epidermal Growth Factor Receptor Mutations
    De Pas, Tommaso
    Toffalorio, Francesca
    Manzotti, Michela
    Fumagalli, Caterina
    Spitaleri, Gianluca
    Catania, Chiara
    Delmonte, Angelo
    Giovannini, Monica
    Spaggiari, Lorenzo
    de Braud, Filippo
    Barberis, Massimo
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (11) : 1895 - 1901
  • [24] Transformation of lung adenocarcinoma into small cell lung cancer after treatment with epidermal growth factor receptor tyrosine kinase inhibitors
    Linwu Kuang
    Yangkai Li
    Oncology and Translational Medicine, 2024, 10 (06) : 286 - 291
  • [25] Leukocyte Telomere Length and Clinical Outcomes of Advanced Lung Adenocarcinoma Patients with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment
    Li, Ji
    Zhang, Li
    Zhu, Hui
    Pan, Wenting
    Zhang, Nasha
    Li, Yankang
    Yang, Ming
    DNA AND CELL BIOLOGY, 2018, 37 (11) : 903 - 908
  • [26] Identification of Epidermal Growth Factor Receptor Tyrosine-Kinase Mutations in Non-small Cell Lung Cancer: Testing Platform Matters
    Gandhi, Shipra
    Kapoor, Ankita
    Dy, Grace
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (03)
  • [27] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Depression
    Pirl, William F.
    Solis, Jessica
    Greer, Joseph
    Sequist, Lecia
    Temel, Jennifer S.
    Lynch, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (23) : E49 - E50
  • [28] Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
    Wozniak, Antoinette J.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (11) : S1084 - S1085
  • [29] Complex Epidermal Growth Factor Receptor Mutations and Their Responses to Tyrosine Kinase Inhibitors in Previously Untreated Advanced Lung Adenocarcinomas
    Zhang, Bo
    Wang, Shuyuan
    Qian, Jie
    Yang, Wenjia
    Qian, Fangfei
    Lu, Jun
    Zhang, Yanwei
    Qiao, Rong
    Han, Baohui
    CANCER, 2018, 124 (11) : 2399 - 2406
  • [30] Frequency of epidermal growth factor receptor mutations in Bangladeshi patients with adenocarcinoma of the lung
    Shakibur Rahman
    Nobuyuki Kondo
    Kazue Yoneda
    Teruhisa Takuwa
    Masaki Hashimoto
    Hayato Orui
    Yoshitomo Okumura
    Fumihiro Tanaka
    Kanako Kumamoto
    Mohammad Golam Mostafa
    Golam Mohiuddin Akbar Chowdhury
    Akramul Haque
    Seiki Hasegawa
    International Journal of Clinical Oncology, 2014, 19 : 45 - 49